And People Who Paid $350K Would Have Serious Buyer's Remorse | GenomeWeb

Blogger Thomas Mailund muses about what he would do if $1,000 genomes were readily available in the next year. Since his focus is on finding disease associations, he says the big difference would come from the ability to detect more variants. "With SNP chips and tagging SNPs, we are looking for high-frequent variants with modest effect," he writes. "With full sequencing, we will be able to look for low frequency variants as well."

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.